Skip to main content

Bleomycin and metal interactions

  • Chapter
Metal Compounds in Cancer Therapy

Abstract

The bleomycins were first isolated in 1966 as a copper complex from a culture of Streptomyces verticillusby Umezawa et al. (1966). The bleomycins are a group of glycopeptide antibiotics possessing antitumour properties against several animal and human tumour lines. Early fractionation studies on the isolated bleomycin complex revealed at least 12 different components, with bleomycin A2 accounting for 55-70% and bleomycin B2 25-32% of clinical preparations (Figure 9.1). The pharmacological activity of bleomycin (A2, B2) is defined (and units of activity standardized) by its antimicrobial activity towards the bacterium Mycobacterium smegmatis(Lightbown, Gutteridge and Shute, 1981). Bleomycin sulphate, used clinically, has an activity of around 1.7 mg units/mg solid. It is a hygroscopic powder with considerable toxicity if inhaled. Opened ampoules or vials should therefore be carefully handled in appropriate safety cabinets. The International Reference Preparation of bleomycin containing 8910 International Units of bleomycin per ampoule can be obtained from the National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN63QG, UK.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Babior, B. M. (1978) Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med., 298, 659–668, 721-5.

    Article  PubMed  CAS  Google Scholar 

  • Blake, D. R., Winyard, R., Lunec, J. et al. (1985) Cerebral and ocular toxicity induced by desferrioxamine. Q. J. Med., 219, 345–355.

    Google Scholar 

  • Blum, R. H., Carter, S. K., and Agre, K. A. (1973) A clinical review of bleomycin: a new antineoplastic agent. Cancer, 31, 903–914.

    Article  PubMed  CAS  Google Scholar 

  • Burger, R. M., Peisach, J. and Horwitz, S. B. (1982) Stoichiometry of DNA strand scission and aldehyde formation by bleomycin. J. Biol. Chem., 257, 8612–8614.

    PubMed  CAS  Google Scholar 

  • Burger, R. M., Berkowitz, A. R., Peisach, J. et al. (1980) Origin of malondialdehyde from DNA degraded by Fe(II)-bleomycin. J. Biol Chem., 225, 11832–11838.

    Google Scholar 

  • Caspary, W. J., Lanzo, D. A. and Niziak, C. (1981) Intermediates in the ferrous oxidase cycle of bleomycin. Biochemistry, 20, 3868–3875.

    Article  PubMed  CAS  Google Scholar 

  • Caspary, W. J., Niziak, C., Lanzo, D. A. et al. (1979) Bleomycin A2: a ferrous oxidase. Mol Pharmacol, 16, 256–290.

    PubMed  CAS  Google Scholar 

  • Chien, M., Grollman, A. P. and Horwitz, S. B. (1977) Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies. Biochemistry, 16, 3641–3647.

    Article  CAS  Google Scholar 

  • Crooke, S. T. and Bradner, W. T. (1976) Bleomycin, a review. J. Med., 7, 333–428.

    PubMed  CAS  Google Scholar 

  • Dabrowiak, J. C. (1980) The coordination chemistry of bleomycin: a review. J. Inorg. Biochem., 13, 317–337.

    Article  CAS  Google Scholar 

  • Dedon, P. C. and Goldberg, I. H. (1992) Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the anti-tumor antibiotics bleomycin, neocarzinostatin and calichaemicin. Chem. Res. Toxi-col, 5, 311–331.

    Article  CAS  Google Scholar 

  • Fenton, J. H. J. (1984) Oxidation of tartaric acid in the presence of iron. J. Chem. Soc., 65, 899–903.

    Google Scholar 

  • Fridovich, I. (1974) Superoxide dismutase. Adv. Enzymol, 41, 35–48.

    PubMed  CAS  Google Scholar 

  • Fridovich, I. (1986) Biological effects of the Superoxide radical. Arch. Biochem. Biophys., 247, 1–11.

    Article  PubMed  CAS  Google Scholar 

  • Giloni, L., Takeshita, M., Johnson, F. et al. (1981) Bleomycin-induced strand-scission of DNA. Mechanisms of deoxyribose cleavage. J. Biol. Chem., 256, 8608–8615.

    PubMed  CAS  Google Scholar 

  • Goldstein, S. and Czapski, G. (1987) Oxidation-reduction reactions of iron bleomycin in the absence and presence of DNA. Free Rad. Res. Commun., 2, 259–270.

    Article  CAS  Google Scholar 

  • Grollman, A. P. and Takeshita, M. (1980) Interactions of bleomycin with DNA. Adv. Enzyme Regul, 18, 67–83.

    Article  PubMed  CAS  Google Scholar 

  • Grollman, A. P., Takeshita, M, Pillai, K. M. et al. (1985) Origin and cytotoxic properties of base propenals derived from DNA. Cancer Res., 45, 1127–1131.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. (1979) Identification of malondialdehyde as the TBA-reactant formed by bleomycin-iron free radical damage to DNA. Fed. Eur. Biochem. Soc. Lett., 105, 278–282.

    Article  CAS  Google Scholar 

  • Gutteridge, J. M. C. (1985) Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels: implications for a wider protective role. Fed. Eur. Biochem. Sci. Lett., 185, 19–23.

    Article  CAS  Google Scholar 

  • Gutteridge, J. M. C. (1986) Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochim. Biophys. Acta, 869, 119–127.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. (1987) Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin. Biochem. J., 245, 415–421.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. (1988) Bleomycin-iron in biological fluids. What does the assay measure? in Free Radicals, Methodology and Concepts (eds C. Rice-Evans and B. Halliwell), Richelieu Press, London, pp. 429–446.

    Google Scholar 

  • Gutteridge, J. M. C. (1991b) Plasma ascorbate levels and inhibition of the antioxidant activity of caeruloplasmin. Clin. Sci., 81, 413–417.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. (1991a) Metalloproteins as donors of metal ions for oxygen chemistry, in Oxidative Damage and Repair. Chemical, Biological and Medical Aspects (ed. K. J. A. Davies), Pergamon Press, Oxford, pp. 355–363.

    Google Scholar 

  • Gutteridge, J. M. C. (1992) Ferrous ions detected in cerebrospinal fluid by using bleomycin and DNA damage. Clin. Sci., 82, 315–320.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. and Fu, X.-C. (1981a) Enhancement of bleomycin-iron free radical damage to DNA by antioxidants and their inhibition of lipid peroxi-dation. Fed. Eur. Biochem. Soc. Lett., 123, 71–74.

    Article  CAS  Google Scholar 

  • Gutteridge, J. M. C. and Fu, X.-C. (1981b) Protection of iron-catalysed free radical damage to DNA and lipids by copper (II)-bleomycin. Biochem. Biophys. Res. Commun., 99, 1354–1360.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. and Halliwell, B. (1989) Iron toxicity and oxygen radicals, in Clinical Haematology: Iron Chelating Therapy (ed. C. Hershko), Bailliere Tindall, London, pp. 195–256.

    Google Scholar 

  • Gutteridge, J. M. C. and Hou, Y. (1986) Iron complexes and their reactivity in the bleomycin assay for radical promoting loosely-bound iron. Free Rad. Res. Commun., 2, 143–151.

    Article  CAS  Google Scholar 

  • Gutteridge, J. M. C., and Shute, D. J. (1981) Iron-dioxygen-dependent changes to the biological activities of bleomycin. J. Inorg. Biochem., 15, 349–357.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C. and Wilkins, S. (1984) Non-protein-bound iron within bacterial cells and the action of bleomycin. Biochem. Int., 8, 89–94.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Beard, A. P. and Quinlan, G. J. (1985a) Catalase enhances damage to DNA by bleomycin-iron(II): the role of hydroxyl radicals. Biochem. Int., 10, 441–449.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Cao, W. and Chevion, M. (1991) Bleomycin-detectable iron in brain tissue. Free Rad. Res. Commun., 11, 317–320.

    Article  CAS  Google Scholar 

  • Gutteridge, J. M. C., Quinlan, G. J. and Evans, T. W. (1994) Transient iron-overload with bleomycin-detectable iron in the plasma of patients with adult respiratory distress syndrome. Thorax, 49, 707–710.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Rowley, D. A. and Halliwell, B. (1981a) Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of ‘free’ iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem. J., 199, 263–265.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Paterson, S. K., Segal, A. W. et al. (1981b) Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem. J., 199, 259–261.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Rowley, D. A., Halliwell, B. et al. (1982) Increased non-protein-bound iron and decreased protection against Superoxide radical damage in cerebrospinal fluids from patients with neuronal ceroid lipofusci-nosis. Lancet, 2, 459–460.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Rowley, D. A., Griffiths, E. et al. (1985b) Low-molecular weight iron complexes and oxygen radical reactions in idiopathic haemo-chromatosis. Clin. Sci., 68, 463–467.

    PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Rowley, D. A., Halliwell, B. et al. (1985c) Copper and iron complexes catalytic for oxygen radical reactions in sweat from human athletes. Clin. Chim. Acta, 145, 267–273.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J. M. C., Winyard, P., Brailsford, S. et al. (1986) Bleomycin-detectable iron in knee-joint synovial fluid from patients with rheumatoid arthritis. Relationship to the iron loading of transferrin, in Free Radicals, Cell Damage and Disease (ed. C. Rice-Evans), Richelieu Press, London, pp. 39–44.

    Google Scholar 

  • Gutteridge, J. M. C., West, M., Eneff, K. et al. (1990) Bleomycin-iron damage to DNA with formation of 8-hydroxydeoxy guanosine and base propenals. Indications that xanthine oxidase generates Superoxide from DNA degradation products. Free Rad. Res. Commun., 10, 159–165.

    Article  CAS  Google Scholar 

  • Haidle, C. W., Weiss, K. K. and Kuo, M. T. (1972) Release of free bases from de-oxyribonucleic acid after reaction with bleomycin. Mol Pharmacol, 8, 531–537.

    PubMed  CAS  Google Scholar 

  • Halliwell, B., Aruoma, O. I., Mufti, G. et al. (1988) Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Fed. Eur. Biochem. Soc. Lett., 241, 202–204.

    Article  CAS  Google Scholar 

  • Kanao, M., Tomita, S., Ishida, S. et al. (1973) Chemotherapy (Tokyo), 21, 1305–1310.

    CAS  Google Scholar 

  • Kuo, M. T. and Haidle, C. W. (1973) Characterisation of chain breakage in DNA induced by bleomycin. Biochim. Biophys. Acta, 335, 109–114.

    CAS  Google Scholar 

  • Lightbown, J. W., Gutteridge, J. M. C. and Shute, D. (1981) The international reference preparation of bleomycin. J. Biol. Standard., 9, 253–263.

    Article  CAS  Google Scholar 

  • Muller, W. E. G., Yamazaki, Z., Breter, H. et al. (1972) Action of bleomycin on DNA and RNA. Eur. J. Biochem., 31, 518–525.

    Article  PubMed  CAS  Google Scholar 

  • Oberley, L. W. and Buettner, G. R. (1979) The production of hydroxyl radicals by bleomycin and iron(II). Fed. Eur. Biochem. Soc. Lett., 97, 47–49.

    Article  CAS  Google Scholar 

  • Rowley, D. A., Gutteridge, J. M. C., Blake, D. R. et al. (1984) Lipid peroxidation in rheumatoid arthritis. Thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin. Sci., 66, 691–695.

    PubMed  CAS  Google Scholar 

  • Sausville, E. A., Peisach, K. and Horwitz, S. B. (1976) A role for ferrous ions and oxygen in the degradation of DNA by bleomycin. Biochemical and Biophysical Research Communications, 73, 814–822.

    Article  PubMed  CAS  Google Scholar 

  • Sebti, S. M., Mignano, J. E., Jani, J. P. et al. (1989) Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry, 28, 6544–6548.

    Article  PubMed  CAS  Google Scholar 

  • Shuttleworth, D., Spence, C. and Slade, B. (1983) Meningism due to intravenous iron dextran. Lancet, 2, 435.

    Google Scholar 

  • Solomon, L. R., Beerelli, R. D. and Mosely, P. L. (1989) Bleomycin-iron can degrade DNA in the presence of excess ethylene-diaminetetracetic acid in vitro. Biochemistry, 28, 9932–9937.

    Article  PubMed  CAS  Google Scholar 

  • Sugiura, Y. (1980) Bleomycin-iron complexes. Electron spin resonance study, ligand effect, and implication for action mechanism. J. Am. Chem. Soc., 102, 5208–5215.

    Article  CAS  Google Scholar 

  • Suzuki, H., Nagai, K., Akutsu, E. et al. (1970) On the mechanism of action of bleomycin strand scission of DNA caused by bleomycin and its binding to DNA in vitro. J. Antibiot., 23, 473–480.

    Article  PubMed  CAS  Google Scholar 

  • Takeshita, M., Grollman, A. P., Ohtsubo, E. et al. (1978) Interaction of bleomycin with DNA. Froc. Nat. Acad. Sci. USA, 75, 5983–5987.

    Article  CAS  Google Scholar 

  • Templin, J., Berry, L., Lyman, S. et al. (1992) Properties of redox-inactivated bleomycins: in vitro DNA damage and inhibition of Ehrlich cell proliferation. Biochem. Pharmacol, 43, 615–623.

    Article  PubMed  CAS  Google Scholar 

  • Umezawa, H. (1976) Bleomycin: discovery, chemistry and action. Gann Monogr. Cancer Res., 19, 3–36.

    CAS  Google Scholar 

  • Umezawa, H. (1979) Advances in bleomycin studies, in Bleomycin, Chemical, Biochemical and Biological Aspects (ed. S. M. Hecht), Springer-Verlag, New York, pp. 24–36.

    Chapter  Google Scholar 

  • Umezawa, H., Maeda, K., Takeuchi, T. et al. (1966) New antibiotics, bleomycin A and B. J. Antibiot. (Tokyo) Ser. A, 19, 200–209.

    CAS  Google Scholar 

  • Umezawa, H., Hori, S., Tsutomu, S. et al. (1974) A bleomycin-inactivating enzyme in mouse liver. J. Antibiot. (Tokyo) Ser. A, 27, 419–424.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Gutteridge, J.M.C. (1994). Bleomycin and metal interactions. In: Fricker, S.P. (eds) Metal Compounds in Cancer Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1252-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1252-9_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4545-2

  • Online ISBN: 978-94-011-1252-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics